Acknowledgements
This meeting report drew heavily upon the final reports of the first Human Variome Project Meeting, and the authors thank all meeting participants for their contributions. They especially thank David Rimoin, Peter Byers, Graham Taylor, Sue Richards, Richard Gibbs, Pat Concannon, Charles Scriver, Anthony Brookes, Lincoln Stein, Donna Maglott, Jose-Maria Cantu, Samir Brahmachari, Kevin Becker, Bernard Mulligan and Michael Katz for chairing the sessions and providing the reports. Huijun Z Ring is an investigator in NIH Pharmacogenetics Research Network and is supported by the NIH funded Pharmacogenetic Center on Nicotine Addiction and Treatment (DA20830). Richard Cotton is supported by the National Health and Medical Research Council, Australia.
Additional information
Funding
This meeting report drew heavily upon the final reports of the first Human Variome Project Meeting, and the authors thank all meeting participants for their contributions. They especially thank David Rimoin, Peter Byers, Graham Taylor, Sue Richards, Richard Gibbs, Pat Concannon, Charles Scriver, Anthony Brookes, Lincoln Stein, Donna Maglott, Jose-Maria Cantu, Samir Brahmachari, Kevin Becker, Bernard Mulligan and Michael Katz for chairing the sessions and providing the reports. Huijun Z Ring is an investigator in NIH Pharmacogenetics Research Network and is supported by the NIH funded Pharmacogenetic Center on Nicotine Addiction and Treatment (DA20830). Richard Cotton is supported by the National Health and Medical Research Council, Australia.